Published in J Genet Couns on January 26, 2012
Attitudes of African Americans toward return of results from exome and whole genome sequencing. Am J Med Genet A (2013) 1.21
Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice. Genet Med (2012) 1.17
Direct-to-Consumer Genetic Testing and Personal Genomics Services: A Review of Recent Empirical Studies. Curr Genet Med Rep (2013) 1.16
Genetics patients' perspectives on clinical genomic testing. Per Med (2013) 1.07
Attitudes of non-African American focus group participants toward return of results from exome and whole genome sequencing. Am J Med Genet A (2014) 0.89
Internet-Based Direct-to-Consumer Genetic Testing: A Systematic Review. J Med Internet Res (2015) 0.81
Primary care patients' views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study. J Community Genet (2013) 0.81
Attitudes towards personal genomics among older Swiss adults: An exploratory study. Appl Transl Genom (2016) 0.79
Racial minority group interest in direct-to-consumer genetic testing: findings from the PGen study. J Community Genet (2017) 0.79
Perceptions of African-American health professionals and community members on the participation of children and pregnant women in genetic research. Public Health Genomics (2013) 0.75
Interest in genomic SNP testing for prostate cancer risk: a pilot survey. Hered Cancer Clin Pract (2015) 0.75
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr (2013) 6.18
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA (2012) 4.71
Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet (2009) 3.76
Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. Am J Epidemiol (2010) 3.64
An agenda for research on the sustainability of public health programs. Am J Public Health (2011) 3.41
A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08
Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet (2008) 2.45
Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev (2002) 2.45
RNA induction and inheritance of epigenetic cardiac hypertrophy in the mouse. Dev Cell (2008) 2.23
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst (2012) 2.21
Developmental control of nuclear size and shape by Kugelkern and Kurzkern. Curr Biol (2006) 2.07
Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1. Antimicrob Agents Chemother (2005) 2.07
The miR-124-Sox9 paramutation: RNA-mediated epigenetic control of embryonic and adult growth. Development (2009) 1.83
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res (2007) 1.82
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A (2009) 1.81
Twelve-month outcomes of an Internet-based diabetes self-management support program. Patient Educ Couns (2011) 1.64
Recruitment for an internet-based diabetes self-management program: scientific and ethical implications. Ann Behav Med (2010) 1.56
Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies. Genet Med (2013) 1.55
The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction. FASEB J (2002) 1.54
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One (2008) 1.50
Reliability and validity of the Sedentary Behavior Questionnaire (SBQ) for adults. J Phys Act Health (2010) 1.48
Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev (2005) 1.44
Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research. Genet Med (2012) 1.39
Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res (2006) 1.37
Outcomes of minimal and moderate support versions of an internet-based diabetes self-management support program. J Gen Intern Med (2010) 1.34
Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis. Stem Cells (2008) 1.32
Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev (2008) 1.30
Rapid active zone remodeling during synaptic plasticity. J Neurosci (2011) 1.24
The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women. Int J Cancer (2008) 1.24
Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.23
Biobanking for research: a survey of patient population attitudes and understanding. J Community Genet (2013) 1.20
Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions. Pharmacol Ther (2009) 1.19
A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet (2010) 1.18
Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet (2011) 1.17
Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. Hum Mol Genet (2010) 1.16
Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev (2012) 1.15
Oxygen-regulated expression of the Wilms' tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). FASEB J (2003) 1.13
The Wilms' tumor gene Wt1 is required for normal development of the retina. EMBO J (2002) 1.13
PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis (2009) 1.13
The complex life of WT1. J Cell Sci (2003) 1.13
Miz1 is required to maintain autophagic flux. Nat Commun (2013) 1.12
Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype. Cancer (2009) 1.11
Primary care and public health partnerships for implementing pre-exposure prophylaxis. Am J Prev Med (2013) 1.08
Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. Cancer Res (2010) 1.06
A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J Clin Endocrinol Metab (2010) 1.04
No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.03
Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). Hum Mol Genet (2009) 1.01
Analysis of cohort studies with multivariate and partially observed disease classification data. Biometrika (2010) 1.01
Risk factors for fatal breast cancer in African-American women and White women in a large US prospective cohort. Am J Epidemiol (2005) 1.00
KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev (2012) 1.00
A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Res (2005) 1.00
Haplotypes of the estrogen receptor beta gene and breast cancer risk. Int J Cancer (2008) 0.99
Kaiser Permanente's performance improvement system, Part 4: Creating a learning organization. Jt Comm J Qual Patient Saf (2011) 0.99
Reliability and validity of brief psychosocial measures related to dietary behaviors. Int J Behav Nutr Phys Act (2010) 0.99
A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Breast Cancer Res (2006) 0.97
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev (2009) 0.97
Chemokine receptor CCR-5 inhibitors produced by Chaetomium globosum. J Nat Prod (2006) 0.97
Facilitators and Barriers to Implementing Screening, Brief Intervention, and Referral to Treatment (SBIRT) in Primary Care in Integrated Health Care Settings. Subst Abus (2014) 0.97
Predicting cancer prognosis using interactive online tools: a systematic review and implications for cancer care providers. Cancer Epidemiol Biomarkers Prev (2013) 0.97
Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway. EMBO Rep (2013) 0.95
Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. Genet Med (2013) 0.95
Large-scale fine mapping of the HNF1B locus and prostate cancer risk. Hum Mol Genet (2011) 0.94
Weight loss and postmenopausal breast cancer in a prospective cohort of overweight and obese US women. Cancer Causes Control (2011) 0.90
Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. Hum Genet (2011) 0.90
Sch 213766, a novel chemokine receptor CCR-5 inhibitor from Chaetomium globosum. J Antibiot (Tokyo) (2007) 0.89
An inducible mouse model for PAX2-dependent glomerular disease: insights into a complex pathogenesis. Curr Biol (2006) 0.89
Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen. Int J Cancer (2010) 0.89
The Wilms tumor suppressor Wt1 promotes cell adhesion through transcriptional activation of the alpha4integrin gene. J Biol Chem (2006) 0.88
Introducing wicked issues for HIV pre-exposure prophylaxis implementation in the U.S. Am J Prev Med (2013) 0.86
Brief physical activity-related psychosocial measures: reliability and construct validity. J Phys Act Health (2011) 0.86
Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database. BMC Cancer (2012) 0.86
Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocrinol Metab (2014) 0.85
The Wilms' tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b). Gene (2003) 0.85
Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is highly expressed in liposarcoma and promotes migration and proliferation. J Pathol (2011) 0.84
Adopting an Evidence-Based Lifestyle Physical Activity Program: Dissemination Study Design and Methods. Transl Behav Med (2012) 0.82
CYP17 genotype predicts serum hormone levels among pre-menopausal women. Hum Reprod (2005) 0.82
Utilization of HER2 genetic testing in a multi-institutional observational study. Am J Manag Care (2012) 0.82
PU.1 (Sfpi1), a pleiotropic regulator expressed from the first embryonic stages with a crucial function in germinal progenitors. Development (2007) 0.81
Family history of various cancers and pancreatic cancer mortality in a large cohort. Cancer Causes Control (2009) 0.81
Two selective novel triterpene glycosides from sea cucumber, Telenata Ananas: inhibitors of chemokine receptor-5. Bioorg Med Chem Lett (2002) 0.81
Cryopreservation of whole blood samples collected in the field for a large epidemiologic study. Cancer Epidemiol Biomarkers Prev (2007) 0.81
Robust Generation of Cardiomyocytes from Human iPS Cells Requires Precise Modulation of BMP and WNT Signaling. Stem Cell Rev (2015) 0.79
Role of the Wilms' tumour transcription factor, Wt1, in blood vessel formation. Pflugers Arch (2008) 0.79
The Nup155-mediated organisation of inner nuclear membrane proteins is independent of Nup155 anchoring to the metazoan nuclear pore complex. J Cell Sci (2012) 0.79
PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1. Pflugers Arch (2010) 0.79
Concerning the CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis (2002) 0.79
Using Implementation and Dissemination Concepts to Spread 21st-century Well-Child Care at a Health Maintenance Organization. Perm J (2009) 0.79
Noise and hearing protection: Latino construction workers' experiences. AAOHN J (2007) 0.78
Pre-processing of ultraviolet resonance Raman spectra. Analyst (2011) 0.78
Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). BMC Cancer (2009) 0.78
Neointimal hyperplasia in allogeneic and autologous venous grafts is not different in nature. Histochem Cell Biol (2015) 0.78